Miromatrix Medical Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | |
|---|---|---|---|
| Revenue | $953,470 | $33,066 | $46,530 |
| Operating income | −$30.4M | −$17.0M | −$10.3M |
| Net income | −$30.0M | −$14.7M | −$10.3M |
| Total assets | $34.8M | $60.9M | $5.3M |
| Total liabilities | $8.7M | $6.8M | $9.6M |
| Equity | $26.1M | $54.1M | −$51.0M |
| EPS (diluted) | $-1.45 | $-1.28 | $-4.76 |
| Shares out. | 20.5M | 20.4M | 2.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −3184.6%
- Net margin
- −3142.2%
- Return on equity
- −114.8%
- Return on assets
- −86.2%
- Return on capital (ROCE)
- −101.8%
- Liabilities / assets
- 24.9%
- Debt / equity
- 0.33×
- Book value / share
- $1.27
- Revenue growth (YoY)
- 2783.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -8.24distress
- Accruals / assets
- −9.4%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsDec 18, 2023
- Results of operationsNov 14, 2023
- Entered a material agreement · Regulation FD disclosureOct 30, 2023
- Results of operationsAug 14, 2023
- Shareholder voteJun 2, 2023
- Director / officer change · Regulation FD disclosureJun 1, 2023
- Results of operationsMay 11, 2023
- Results of operationsMar 31, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.